Carl Zeiss AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Carl Zeiss AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7128
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carl Zeiss AG (Carl Zeiss) is a medical technology with focus on optical and optoelectronic industry. It develops and distributes lithography optics, measuring technology, photomask systems, microscopes, medical technology products including ophthalmic diagnostic and therapeutic products, eyeglass lenses, camera and cine lenses, binoculars and planetarium technology. The company offers its products and services to a wide range of sectors including semiconductor, automotive and mechanical engineering industries, and biomedical research and medical technology. It has research and development and manufacturing facilities in Europe, North America, Central America and Asia. Carl Zeiss is headquartered in Oberkochen, Germany.

Carl Zeiss AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Carl Zeiss AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Carl Zeiss AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Carl Zeiss AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Carl Zeiss AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Carl Zeiss AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Carl Zeiss AG, Medical Equipment, Deal Details 11
Asset Purchase 11
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 11
Partnerships 12
Carl Zeiss Vision Enters Into Cross-Licensing Agreement With Rodenstock 12
Indizen Optical Technologies Enters Into Licensing Agreement With Carl Zeiss Vision For Patent Technology 13
Vision-Ease Enters Into Licensing Agreement With Carl Zeiss Vision For Freeform Technology 14
Carl Zeiss Vision Enters Into Licensing Agreement With Hoya Vision Care For Patent Technology 15
Olympus America Enters Into Licensing Agreement With Carl Zeiss MicroImaging 16
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 17
Carl Zeiss Meditec Enters Into Distribution Agreement With Henry Schein Dental 18
Carl Zeiss Microscopy Enters Into Agreement With Gatan To Develop 3D Imaging System 19
Equity Offering 20
Carl Zeiss Meditec Raises USD340 Million in Private Placement of Shares 20
Acquisition 22
Carl Zeiss Meditec Acquires Aaren Scientific For US$70 Million 22
Carl Zeiss Meditec Acquires Optronik 23
Carl Zeiss Completes Acquisition Of Xradia 24
Carl Zeiss Receives Approval From European Commission To Acquire Remaining Stake In Carl Zeiss Vision 26
Carl Zeiss Acquires Brock & Michelsen, Medical Equipment Distributor 27
Carl Zeiss AG – Key Competitors 28
Carl Zeiss AG – Key Employees 29
Carl Zeiss AG – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Affiliate 32
Recent Developments 33
Strategy And Business Planning 33
Feb 28, 2018: Dedicated training center for ophthalmologists inaugurated in Asuncion 33
Financial Announcements 34
Aug 10, 2018: Quarterly Report of Carl Zeiss Meditec 34
May 18, 2018: ZEISS Presents Half-Year Figures: High Tech Drives Growth 36
Dec 13, 2017: Record Revenue and Earnings: ZEISS Continues Growth Trajectory 38
May 11, 2017: ZEISS: Significant Growth in Revenue and Earnings 40
Corporate Communications 42
Jul 12, 2018: New Chief Financial Officers Appointed at Carl Zeiss and Carl Zeiss Meditec 42
Jul 12, 2018: Carl Zeiss Meditec Announces New CFO and Expansion of the Management Board 44
Feb 28, 2018: Dedicated training center for ophthalmologists inaugurated in Asuncion 45
Dec 12, 2017: New members of the Executive Board of the ZEISS Group 46
Mar 21, 2017: Dieter Kurz Confirmed as Chairman of the Supervisory Boards at SCHOTT and ZEISS 48
Product News 49
Aug 20, 2018: ZEISS offers greater flexibility with optical CMM inspection 49
Aug 06, 2018: ZEISS to present initial release of APEER, its digital microscopy platform for applications in science and industry 50
May 17, 2018: ZEISS hosts Day of Microscopy 2018 51
May 03, 2018: Innovative ZEISS Solutions for Managing Widespread Myopia 52
May 03, 2018: ZEISS presents new enhanced software technology 55
Jan 12, 2018: ZEISS launches platform for 3D centration data determination 56
Dec 12, 2017: ZEISS introduces machine learning capability for microscopy 57
May 08, 2017: Open Innovation of ZEISS and the Advanced Retina Imaging Network advances Swept-Source OCT technology for better vision care 58
Mar 15, 2017: ZEISS Crossbeam 550 sets new standards in 3D analytics and sample preparation 59
Other Significant Developments 60
Jan 31, 2018: ZEISS Publishes First Group Sustainability Report after Fiscal Year 2016/17 60
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62

List of Tables
Carl Zeiss AG, Medical Equipment, Key Facts, 2017 2
Carl Zeiss AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Carl Zeiss AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Carl Zeiss AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Carl Zeiss AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Carl Zeiss AG, Deals By Market, 2012 to YTD 2018 9
Carl Zeiss AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 11
Carl Zeiss Vision Enters Into Cross-Licensing Agreement With Rodenstock 12
Indizen Optical Technologies Enters Into Licensing Agreement With Carl Zeiss Vision For Patent Technology 13
Vision-Ease Enters Into Licensing Agreement With Carl Zeiss Vision For Freeform Technology 14
Carl Zeiss Vision Enters Into Licensing Agreement With Hoya Vision Care For Patent Technology 15
Olympus America Enters Into Licensing Agreement With Carl Zeiss MicroImaging 16
Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 17
Carl Zeiss Meditec Enters Into Distribution Agreement With Henry Schein Dental 18
Carl Zeiss Microscopy Enters Into Agreement With Gatan To Develop 3D Imaging System 19
Carl Zeiss Meditec Raises USD340 Million in Private Placement of Shares 20
Carl Zeiss Meditec Acquires Aaren Scientific For US$70 Million 22
Carl Zeiss Meditec Acquires Optronik 23
Carl Zeiss Completes Acquisition Of Xradia 24
Carl Zeiss Receives Approval From European Commission To Acquire Remaining Stake In Carl Zeiss Vision 26
Carl Zeiss Acquires Brock & Michelsen, Medical Equipment Distributor 27
Carl Zeiss AG, Key Competitors 28
Carl Zeiss AG, Key Employees 29
Carl Zeiss AG, Subsidiaries 30
Carl Zeiss AG, Affiliate 32

List of Figures
Carl Zeiss AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Carl Zeiss AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Carl Zeiss AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Carl Zeiss AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Carl Zeiss AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Carl Zeiss AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Carl Zeiss AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Carl Zeiss AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Carl Zeiss AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Myriad Group AG:企業の戦略的SWOT分析
    Myriad Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Petkim Petrokimya Holding AS (PETKM):企業の財務・戦略的SWOT分析
    Summary Petkim Petrokimya Holding AS (Petkim Petrokimya), a subsidiary of State Oil Company of the Azerbaijan Republic, is a chemical company. Its products portfolio includes propylene, acrylonitrile, ethylene, polyvinyl chloride, aromatics, polypropylene, sodium hydroxide, diethylene glycol, polyme …
  • Simply Energy:企業の戦略的SWOT分析
    Simply Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Snap-on Incorporated (SNA):企業の財務・戦略的SWOT分析
    Snap-on Incorporated (SNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Sirius XM Radio Inc. (SIRI):企業の財務・戦略的SWOT分析
    Sirius XM Radio Inc. (SIRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Isagen SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Isagen SA ESP (Isagen), a subsidiary of Brookfield Renewable Energy Partners LP, is an electricity utility. It generates and markets electricity; supplies natural gas; and sells coal, steam, and other energy sources. The company produces electric energy from hydro and natural gas sources. Is …
  • LG Corp (003550):企業の財務・戦略的SWOT分析
    LG Corp (003550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Banyan Biomarkers Inc:企業の製品パイプライン分析2018
    Summary Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company’s product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neur …
  • Severstal:企業の戦略・SWOT・財務情報
    Severstal - Strategy, SWOT and Corporate Finance Report Summary Severstal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Orchids Paper Products Co (TIS):企業の財務・戦略的SWOT分析
    Orchids Paper Products Co (TIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Quarterhill Inc.:企業のM&A・事業提携・投資動向
    Quarterhill Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quarterhill Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • BioCryst Pharmaceuticals Inc (BCRX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioCryst Pharmaceuticals Inc (BioCryst) designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrat …
  • Cadent Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary Cadent Therapeutics (Cadent), formerly Luc Therapeutics Inc, is a precision neuroscience company that offers medicines for serious neurological diseases. The company's products comprise NR2B positive allosteric modulators, NR2A negative allosteric modulators and NR2B negative allosteric modu …
  • Piper Jaffray Companies:企業の戦略・SWOT・財務情報
    Piper Jaffray Companies - Strategy, SWOT and Corporate Finance Report Summary Piper Jaffray Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Appili Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral suspension antibiotic liquid reformulation …
  • Mabuhay Vinyl Corp (MVC):企業の財務・戦略的SWOT分析
    Mabuhay Vinyl Corp (MVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • STMicroelectronics NV (STM):企業の財務・戦略的SWOT分析
    STMicroelectronics NV (STM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • EmCare Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary EmCare Inc (EmCare) is a healthcare service provider that offers emergency department outsourcing services for the hospitals. The center provides emergency medicine, hospital medicine, acute care surgery, anesthesiology and radiology services. It provides recruitment, staffing, management, m …
  • Petsec Energy Ltd (PSA):石油・ガス:M&Aディール及び事業提携情報
    Summary Petsec Energy Ltd (Petsec Energy) is an oil and gas company that offers oil and gas exploration, development, and production. The Company holds interests in two oil and gas production fields located onshore Louisiana, the US in Mystic Bayou and Jeanerette Fields. It provides leases, explorat …
  • Cooper Energy Ltd (COE):石油・ガス:M&Aディール及び事業提携情報
    Summary Cooper Energy Limited (CEL) is an exploration and production company that offers oil production programs. The company explores, produces, and commercializes crude oil and natural gas products. It conducts exploration for oil and gas through a portfolio of prospective acreage in the Cooper, O …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆